Authors:
Saunders, MP
Patterson, AV
Chinje, EC
Harris, AL
Stratford, IJ
Citation: Mp. Saunders et al., NADPH : cytochrome C (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line, BR J CANC, 82(3), 2000, pp. 651-656
Authors:
Ulhaq, S
Chinje, EC
Naylor, MA
Jaffar, M
Stratford, IJ
Threadgill, MD
Citation: S. Ulhaq et al., Heterocyclic analogues of L-citrulline as inhibitors of the isoforms of nitric oxide synthase (NOS) and identification of N-delta-(4,5-dihydrothiazol-2-yl)ornithine as a potent inhibitor, BIO MED CH, 7(9), 1999, pp. 1787-1796
Authors:
Garner, AP
Paine, MJI
Rodriguez-Crespo, I
Chinje, EC
De Montellano, PO
Stratford, IJ
Tew, DG
Wolf, CR
Citation: Ap. Garner et al., Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents, CANCER RES, 59(8), 1999, pp. 1929-1934
Authors:
Chinje, EC
Patterson, AV
Saunders, MP
Lockyer, SD
Harris, AL
Stratford, IJ
Citation: Ec. Chinje et al., Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?, BR J CANC, 81(7), 1999, pp. 1127-1133
Authors:
Ulhaq, S
Chinje, EC
Naylor, MA
Jaffar, M
Stratford, IJ
Threadgill, MD
Citation: S. Ulhaq et al., S-2-amino-5-azolylpentanoic acids related to L-ornithine as inhibitors of the isoforms of nitric oxide synthase (NOS), BIO MED CH, 6(11), 1998, pp. 2139-2149